340B Payment Reductions in the CY2018 Final OPPS Rule
Re: 340B Payment Reductions in the CY2018 Final OPPS Rule
A federal judge today ruled in favor of the AHA and hospital plaintiffs saying that the Department of Health and Human Services “adjustment” by nearly 30 percent of 2018 Medicare payment rates for many hospitals in the 340B Drug Pricing Program was unlawful.
Dec. 27, 2018 court decision in 340B payment case
Notice of Administrative Decisions, Exhibit 1 - Declaration of Krista Pedley and Defendant's reply
The Centers for Medicare & Medicaid Services today issued its calendar year 2019 outpatient prospective payment and ambulatory surgical center final rule, which updates hospital OPPS rates by 1.35 percent in CY 2019 compared to CY 2018.
Plaintiffs essentially allege that they have a statutory entitlement to a government-funded windfall with every drug purchase they make through the 340B Program, and that the Secretary erred by decreasing the amount of the windfall in the final 2018 OPPS Rule. See, e.g., Plaintiffs' Reply in…
THE AMERICAN HOSPITAL ASSOCIATION, et al., Plaintiffs, -v- ALEX M. AZAR II, in his official capacity as the Secretary of Health and Human Services, et al., Defendants. Case No. 18-cv-2084 (RC)
Legal documents related to the government's motion to dismiss filed on Sept. 14, 2018.
Complaint and brief: The American Hospital Association (AHA), the Association of American Medical Colleges (AAMC), and America’s Essential Hospitals, along with three hospital plaintiffs, refiled their lawsuit against the HHS to reverse Medicare payment cuts for many hospitals in the 340B Drug…